MoU inked between SRHU and Auriga Research Pvt Ltd

Published on: October 15, 2024

MoU inked between SRHU and Auriga Research Pvt Ltd

‘Swami Rama Himalayan University’ signed a Memorandum of Understanding (MoU) with ‘Auriga Research Pvt Ltd’ (ARPL) marking a significant step towards enhancing industry collaboration and fostering academic growth.

The MoU aims to strengthen ties between the academic and industrial sectors, with special focus on clinical trials, internships, placements, workshops, and research partnerships. The agreement will provide the faculty, researchers, and students of SRHU opportunity to gain invaluable insights into industrial practices.

Manoj Karwa, Head of Clinical Trials and Pharmacovigilance, ARPL, signed the MoU on behalf of the company. While Dr. Mukesh Bijalwan, Registrar SRHU signed on behalf of SRHU.

Collaborative Activities Under the MoU would include the following –

Internships:

ARPL will actively engage with SRHU to offer internship opportunities to students, subject to the availability of training scopes. Students may undertake short-term (4-6 months) project work or dissertation theses during their final year or semester within the facilities of ARPL.

Placements :
The company will also provide placement opportunities, subject to the availability of recruitment scopes. SRHU will facilitate in-campus or pool campus placement drives, ensuring smooth and efficient placement processes for graduating students.

Workshops and Seminars:
ARPL will collaborate with SRHU to conduct technical sessions, workshops, seminars, and conferences. Industry experts from Auriga will lead these sessions.

Industrial Visits:
The company may permit educational tours for SRHU students, providing them with practical industrial exposure. These visits will be arranged based on feasibility and availability, ensuring that students gain real-world insight into how industry functions.

Academic Participation:
To ensure continuous academic growth, SRHU will invite representatives from ARPL to participate in its Board of Studies and Academic Council. This collaboration will allow for regular updates and upskilling of SRHU’s syllabi to meet industry standards.

Research Partnership:
The MoU also fosters collaborative research opportunities, enabling joint projects and innovation between the two institutions. SRHU’s faculty and students will be able to contribute to and benefit from Auriga’s ongoing clinical trials and research efforts.

From SRHU Dr. Rajendra Dobhal, Vice Chancellor, Dr. Vijendra Chauhan, Director General (Academic Development), Dr. A.K. Deorari, Principal, HIMS, Dr. Bindu Dey, Director, Research Cell marked their presence. Dr A.K Srivastava, HOD Community Medicine, Dr. Nikku Yadav Clinical Research, Dr. Apurvaa Trivedi, HSMS were in attendance.

mou-768x512
   Admissions Form         

Admission Open For 2025

×
International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.